BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 7735330)

  • 1. A novel system to investigate the phosphorylation of the p53 tumor suppressor protein by the protein kinase CK2.
    McKendrick L; Meek DW
    Cell Mol Biol Res; 1994; 40(5-6):555-61. PubMed ID: 7735330
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of protein kinase activities associated with p53-large-T immune complexes from SV40-transformed rat cells.
    Müller E; Boldyreff B; Scheidtmann KH
    Oncogene; 1993 Aug; 8(8):2193-205. PubMed ID: 8393163
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mapping of the interaction sites of the growth suppressor protein p53 with the regulatory beta-subunit of protein kinase CK2.
    Appel K; Wagner P; Boldyreff B; Issinger OG; Montenarh M
    Oncogene; 1995 Nov; 11(10):1971-8. PubMed ID: 7478515
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Purification and characterization of a protein kinase which is activated by SV40 large T-antigen and phosphorylates the tumor suppressor protein p53.
    Müller E; Scheidtmann KH
    Oncogene; 1995 Mar; 10(6):1175-85. PubMed ID: 7700642
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of protein kinase CK2 protein subunits and p53 in F9 teratocarcinoma cells in the absence and presence of cisplatin.
    Küpper M; Köster M; Schmidt-Spaniol I; Wagner-Gillen I; Issinger OG
    Cell Mol Biol Res; 1994; 40(5-6):587-92. PubMed ID: 7735333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of the DNA-binding ability of latent p53 protein by protein kinase C is abolished by protein kinase CK2.
    Pospísilová S; Brázda V; Kucharíková K; Luciani MG; Hupp TR; Skládal P; Palecek E; Vojtesek B
    Biochem J; 2004 Mar; 378(Pt 3):939-47. PubMed ID: 14640983
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phosphorylation by DNAPK inhibits the DNA-binding function of p53/T antigen complex in vitro.
    Sheppard HM; Liu X
    Anticancer Res; 1999; 19(3A):2079-83. PubMed ID: 10470151
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNA damage triggers DRB-resistant phosphorylation of human p53 at the CK2 site.
    Blaydes JP; Hupp TR
    Oncogene; 1998 Aug; 17(8):1045-52. PubMed ID: 9747884
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Specific DNA binding by p53 is independent of mutation at serine 389, the casein kinase II site.
    Rolley N; Milner J
    Oncogene; 1994 Oct; 9(10):3067-70. PubMed ID: 8084615
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Murine p53 is phosphorylated within the PAb421 epitope by protein kinase C in vitro, but not in vivo, even after stimulation with the phorbol ester o-tetradecanoylphorbol 13-acetate.
    Milne DM; McKendrick L; Jardine LJ; Deacon E; Lord JM; Meek DW
    Oncogene; 1996 Jul; 13(1):205-11. PubMed ID: 8700548
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fine mapping and regulation of the association of p53 with p34cdc2.
    Wagner P; Fuchs A; Götz C; Nastainczyk W; Montenarh M
    Oncogene; 1998 Jan; 16(1):105-11. PubMed ID: 9467949
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Growth stimulation of murine fibroblasts by TGF-beta1 depends on the expression of a functional p53 protein.
    Dkhissi F; Raynal S; Jullien P; Lawrence DA
    Oncogene; 1999 Jan; 18(3):703-11. PubMed ID: 9989820
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Post-translational modification of p53.
    Meek DW
    Semin Cancer Biol; 1994 Jun; 5(3):203-10. PubMed ID: 7948948
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immortalization of BALB/c mouse embryo fibroblasts alters SV40 large T-antigen interactions with the tumor suppressor p53 and results in a reduced SV40 transformation-efficiency.
    Tiemann F; Deppert W
    Oncogene; 1994 Jul; 9(7):1907-15. PubMed ID: 8208537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polyomavirus large T antigen overcomes p53 dependent growth arrest.
    Doherty J; Freund R
    Oncogene; 1997 Apr; 14(16):1923-31. PubMed ID: 9150359
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The nuclear serine/threonine protein kinase DNA-PK.
    Anderson CW; Lees-Miller SP
    Crit Rev Eukaryot Gene Expr; 1992; 2(4):283-314. PubMed ID: 1486241
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced binding of RNAP II CTD phosphatase FCP1 to RAP74 following CK2 phosphorylation.
    Abbott KL; Renfrow MB; Chalmers MJ; Nguyen BD; Marshall AG; Legault P; Omichinski JG
    Biochemistry; 2005 Mar; 44(8):2732-45. PubMed ID: 15723518
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Raf phosphorylates p53 in vitro and potentiates p53-dependent transcriptional transactivation in vivo.
    Jamal S; Ziff EB
    Oncogene; 1995 Jun; 10(11):2095-101. PubMed ID: 7784054
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New monoclonal antibodies recognizing p53 protein phosphorylated by casein kinase II at serine 392.
    Pospísilová S; Kanková K; Svitáková M; Nenutil R; Vojtesek B
    Folia Biol (Praha); 2001; 47(4):148-51. PubMed ID: 11508859
    [No Abstract]   [Full Text] [Related]  

  • 20. Simian virus 40 large T antigen and p53 are microtubule-associated proteins in transformed cells.
    Maxwell SA; Ames SK; Sawai ET; Decker GL; Cook RG; Butel JS
    Cell Growth Differ; 1991 Feb; 2(2):115-27. PubMed ID: 1648952
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.